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Abstract:   28 
Innovative tools are essential for advancing malaria control and depend on an understanding of 29 
molecular mechanisms governing transmission of malaria parasites by Anopheles mosquitoes. 30 
CRISPR/Cas9-based gene disruption is a powerful method to uncover underlying biology of 31 
vector-pathogen interactions and can itself form the basis of mosquito control strategies. 32 
However, embryo injection methods used to genetically manipulate mosquitoes (especially 33 
Anopheles) are difficult and inefficient, particularly for non-specialist laboratories. Here, we 34 
adapted the ReMOT Control (Receptor-mediated Ovary Transduction of Cargo) technique to 35 
deliver Cas9 ribonucleoprotein complex to adult mosquito ovaries, generating targeted and 36 
heritable mutations in the malaria vector Anopheles stephensi without injecting embryos. In 37 
Anopheles, ReMOT Control gene editing was as efficient as standard embryo injections. The 38 
application of ReMOT Control to Anopheles opens the power of CRISPR/Cas9 methods to 39 
malaria laboratories that lack the equipment or expertise to perform embryo injections and 40 
establishes the flexibility of ReMOT Control for diverse mosquito species.  41 
 42 
 43 
 44 
  45 
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Introduction: 46 
To solve the growing problem of mosquito-borne disease, we need improved and more 47 
efficient gene editing methods. Targeted disruption of genes in mosquito vectors of human 48 
pathogens is a powerful method to uncover the underlying biology of mosquito pathogen 49 
transmission that can inform the development and application of new approaches to mosquito 50 
and disease control (Dong et al. 2018; Ling and Raikhel 2018; Duvall et al. 2019; Raji et al. 2019; 51 
Matthews et al. 2019). Genome manipulation technologies can themselves form the basis of 52 
mosquito and pathogen control strategies (Kyrou et al. 2018; Binh Pham et al. 2019). While 53 
many techniques based on CRISPR/Cas9 have improved studies in mosquito genetics, these 54 
techniques rely on embryo injection of the Cas9 ribonucleo-protein complex (RNP), which 55 
requires specialized and expensive equipment and training. To get around this bottleneck, a 56 
strategy termed ReMOT Control (Receptor-Mediated Ovary Transduction of Cargo) was 57 
developed for delivery of gene-editing moieties to the arthropod germline from the hemocoel, 58 
allowing targeted and heritable mutations to be made by adult injection instead of embryo 59 
microinjection (Chaverra-Rodriguez et al. 2018). Proof-of-principle experiments validating 60 
ReMOT Control were conducted in Aedes aegypti, but extension of the method to species more 61 
recalcitrant to editing (such as Anopheles mosquitoes) was not established.  62 
In this study, we have adapted the ReMOT Control technique for efficient gene editing in 63 
Anopheles stephensi a major vector of Plasmodium parasites in India and Southeast Asia and so 64 
a major object for malaria research. A transgenic line of An. stephensi containing two 65 
fluorescent markers was already being used to establish protocols Cas9-mediated gene editing 66 
and so this line provided a straight-forward first target for ReMOT Control in Anopheles.  We 67 
found that once optimized, gene editing by ReMOT Control in Anopheles mosquitoes was 68 
comparable to the technique in Ae. aegypti and as efficient in editing as standard embryo 69 
injections. As Anophelines are substantially more difficult to manipulate at the embryo stage 70 
than Aedes mosquitoes, ReMOT Control represents a much-needed improvement in gene 71 
editing for malaria vectors. We expect that with ReMOT Control gene editing will become as 72 
commonly used for reverse genetics in Anopheles mosquitoes as it has become in Aedine 73 
vectors of human arboviruses. 74 
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Materials and Methods: 75 
Mosquitoes: Anopheles stephensi wild type (Liston strain) and the Anopheles stephensi 76 
transgenic line VgCp26.10 were reared at 27 °C, 75 ± 10% relative humidity, 12 h light: 12 h dark 77 
in a walk-in environmental chamber. Larvae were fed with a slurry of 1:2 by volume 78 
Tetramin:baker’s yeast. Adults were provided ad libitum with 10% sterilized sugar on a cotton 79 
ball. For injection experiments female mosquitoes were fed on anonymous human blood 80 
(Biospecialty Corp.) using a water-jacketed membrane feeding system. 81 
Embryo Microinjections: Anopheles stephensi females from a homozygous transgenic line 82 
VgCp26.10 (Binh Pham et al. 2019) were used to generate heterozygous embryos for injection. 83 
Blood-fed An. stephensi mosquitoes were induced to lay eggs 3-5 days after a blood meal by 84 
combining 6-10 females in a narrow Drosophila vial with cotton and Whatman filter paper wet 85 
with isotonic buffer (150mM NaCl, 5mM KCl; 10mM HEPES; 2.5mM CaCl2; pH 7.2). At 86 
approximately 1 hour and 15 minutes after laying, a paintbrush was used to transfer embryos 87 
that were sufficiently melanized to a small piece of filter paper wet with isotonic buffer. Under 88 
a dissecting scope, the outer membrane was removed with jeweler’s forceps from the embryos 89 
and embryos were aligned with posterior poles to the left while maintaining moisture on the 90 
paper. After alignment of 30-70 embryos, the paper was dried briefly, embryos were 91 
transferred to toupee tape on a plastic cover slip and an oil mixture (1:1 Halocarbon 700 oil: 92 
Halocarbon 27 oil) was used to cover the embryos to prevent further desiccation. Quartz 93 
needles were pulled using a Sutter P2000 needle puller and were used with a Femtojet injector 94 
(Eppendorf) and InjectMan micromanipulator. Following injection, oil was removed from 95 
embryos with a Kim Wipe and embryos were submerged on the tape into a petri dish with 96 
isotonic buffer and transferred back to an insectary to hatch. Hatching was monitored daily for 97 
14 days and hatched larvae were immediately transferred to a pan with food. The injection mix 98 
from successful experiments comprised 200ng/uL Streptococcus pyogenes Cas9 (PacBio) and 99 
100ng/µL each of three single guide RNAs initially described for use to target green fluorescent 100 
protein (EGFP) in human cell (12, Table S4). Injected embryos (generation 0, G0) that survived to 101 
adulthood were outcrossed: families comprised five G0 males allowed to mate individually to 10 102 
wild-type females each for 2 days, then combined and pools comprised age-matched G0 103 
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females batch mated to wild-type males. G1 progeny resulting from families and pools were 104 
screened for both red and cyan fluorescence in the eyes. 105 
Adult Injections: Adult females with ages ranging from 5 to 22 days old were blood-fed using a 106 
glass water jacketed membrane feeder. The next day, females were immobilized by incubation 107 
at 4oC until motionless, then placed on ice and sorted. Females with visible blood-meals were 108 
injected intrathoracically using a glass needle drawn from a glass capillary (World Precision 109 
Instruments) using a needle puller (Sutter P2000) and aspirator assembly (A5177, Sigma) until 110 
we could observe visible distention of the abdomen, diuresis or liquid emerging from the 111 
injection site (approximately 200 nl).   112 
Adult Injection Mix Preparation: P2C-Cas9 and P2C-EGFP proteins were expressed from 113 
pET28a-P2C-Cas9 and pRSET-P2C-EGFP respectively by recombinant BL21 E.coli (NEB) as 114 
described previously in detail (Chaverra-Rodriguez et al. 2018).  Single guide RNAs (sgRNAs) 115 
were prepared using a PCR template amplified by CRISPR_F primers designed for each ECFP 116 
target and CRISPR_R primers (Table S4). In vitro transcription was used to produce sgRNAs from 117 
PCR template using either MegaScript T7 or MegaScript RNAi kits with at least 1000ng of PCR 118 
template. Two to four volumes of the in vitro transcription reaction were required to achieve 119 
the high quantities of guide RNA required for adult injections. In addition to P2C-Cas9 and 120 
sgRNAs, saponin was included in some injection mixes. Saponin dilutions were prepared fresh 121 
prior to each injection from dry crude extract of Quillaja bark containing >20% saponin (Sigma-122 
Aldrich). All concentrations of saponin reported here represent concentration of crude extract. 123 
The final step in P2C-Cas9 expression and purification from transformed Escherichia coli is 124 
dialysis of the protein in a pH 8.0 buffer consisting 50 mM Tris-HCl pH 8.0, 200 mM KCl, 0.1 mM 125 
EDTA, 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and 1mM dithiothrietol (DTT). Injections 126 
using this buffer produced a high mortality in An. stephensi females, but we found that 127 
concentrated stocks of P2C-Cas9 protein often precipitated when water, 1X PBS or guide RNA 128 
solutions were added to the protein solution. However, if the P2C-Cas9 protein was diluted in a 129 
large volume (300-500 µL) of 50 mM Tris-HCl pH 8.0, 200 mM KCl and small volumes (~<20 µL) 130 
of highly concentrated (~3-10 µg/µL) sgRNA were added and allowed to complex, the buffer of 131 
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the RNP could then be exchanged with 1X PBS using an Amicon 10K filter column, which retains 132 
the large protein and both bound and unbound guide RNA. Following buffer exchange, saponin, 133 
water and additional sgRNA were added to produce solutions of 0.5-0.75 µg/µL P2C-Cas9, 0.75-134 
1.2 µg/µL of total guide RNA (from a premixed solution of the three sgECFPs), 50 mg/L saponin 135 
extract from Quillaja bark and less than 5 µM residual KCl. 136 
Larval Screening: G0 and G1 larvae were screened at larval instar stage 3 or 4. Larvae were 137 
immobilized by applying larvae to a wet filter paper in a Bϋchner funnel attached to vacuum 138 
filtering flask. Larvae were kept slightly wet during screening under UV fluorescence microscopy 139 
with a Leica dissecting scope or Zeiss Axiozoom.  140 
Imaging: To determine the optimal time for P2C-mediated delivery, adult females were injected 141 
with P2C-EGFP (Chaverra-Rodriguez et al. 2018) 24 hours before and 4, 24, and 48 hours after a 142 
bloodmeal. Adult female ovaries were dissected 72 hours post-blood meal, mounted on a slide 143 
in SlowFade™ Gold Antifade Mountant (Invitrogen) between two double layers of scotch tape 144 
to prevent the ovaries from being squashed by the plastic coverslip. The coverslip was sealed in 145 
place using nail polish on the edges of the slip and ovaries were visualized on Olympus BX41. All 146 
images were captured using 311ms exposure for 200X and 1030ms exposure for 40X images.  147 
Molecular analysis of mutant individuals: Mutant G0 and G1 mosquitoes identified by visual 148 
screening were collected individually and G1 progeny from mutant G0 were collected in groups 149 
of five individuals, frozen and stored at -20oC. Genomic DNA was extracted using Wizard® 150 
Genomic DNA Purification Kit or Qiagen DNeasy® Blood & Tissue kits following the protocol for 151 
extraction of DNA from animal tissues. Genomic DNA was used as a template for PCR using the 152 
NEB Phusion enzyme and using primers against the transgenes and surrounding DNA (Figures 153 
3A, S4). Diagnostic gel bands were extracted using Zymoclean Gel DNA Recovery kit (Zymo, 154 
Irvine) cloned into pJet1.2/blunt using the CloneJET PCR Cloning Kit (ThermoFisher) and 155 
sequenced. Sequence analyses were performed using the DNAstar Lasergene suite. 156 
Data Availability: 157 
All data are described in the text and/or included in tables and figures within the manuscript 158 
and in the supplement uploaded into figshare as follows:  159 
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Figure S1: Alignment of amplicon sequences from PCR B validate the presence of the 160 
transgene in 17 ECFP knockout individuals.  161 
Table S1: Results from screening Single G0 male families (1,2,3 etc.) and Pools (PX)of G0 162 
females injected as embryos with 200 ng/µL Cas9 and three sgRNAs targeting ECFP 163 
(300ng/µL total) 164 
Table S2: Results from screening Single G0 male families (1,2,3 etc.) and Pools (PX) of G0 165 
females injected as embryos with 200 ng/µL Cas9 and three sgRNAs targeting ECFP (total 166 
75ng/µL)  167 
Table S3: Summary of injection components used for G0 embryo injections and resulting 168 
gene-editing detected in G1  169 
Table S4: Primers used for current study 170 
Results and Discussion: 171 
ECFP targeting, mutation detection scheme, and validation by embryo microinjection. 172 
To establish a method for site-specific editing in An. stephensi, we used ReMOT Control to 173 
target one of the two fluorescent marker genes in the transgenic An. stephensi line VgCp26.10 174 
(Binh Pham et al. 2019), which offered several advantages for establishment of mutagenesis 175 
methods over the endogenous eye color genes previously used. The gene encoding kynurenine 176 
5-monooxygenase (kmo or kynurenine hydroxylase, kh) was used as a visible marker to develop 177 
both embryo injection and adult injection methods in Ae. aegypti (Basu et al. 2015; Chaverra-178 
Rodriguez et al. 2018). However, the kmo knockout is associated with substantially decreased 179 
fitness in An. stephensi, while the VgCp26.10 transgenic line is robust and is not likely to suffer 180 
from the phenotypic loss of a fluorescent marker (Gantz et al. 2015; Binh Pham et al. 2019). A 181 
mutation in the one dominant visible fluorescent marker gene (enhanced cyan fluorescence 182 
protein, ECFP) is easy to detect in hemizygous live mosquitoes by fluorescence imaging while 183 
simultaneous expression of the intact linked marker gene (Discosoma species Red, DsRed) 184 
confirms presence of the transgene rather than the wild-type empty locus (Li and Handler 185 
2019). 186 
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Initial validation of targeted knockdown of ECFP in the VgCp26.10 transgenic line by embryo 187 
microinjection provided a benchmark to assess ReMOT Control knockout efficiency. 188 
Homozygous transgenic embryos (generation 0, G0) were injected with Cas9 plasmid expression 189 
cassette, mRNA, or protein, and three single guide RNAs originally designed to target EGFP in 190 
human cells (Zhang et al. 2014) but which also cut ECFP due to a high degree of sequence 191 
conservation between the two genes. Surviving G0 embryos injected with 200 ng/µL Cas9 192 
protein and 300 ng/µL sgRNAs produced G1 offspring lacking cyan fluorescence in the eyes but 193 
expressing DsRed in four out of 32 single male G1 families and one female pool, resulting in 194 
frequencies of 12.5% families producing edited offspring and 1.5-24% of G1 offspring edited 195 
within those families (Table 1 and Table S1). ECFP knockout individuals comprised 1.5% of total 196 
G1 screened across all families. Two male families produced individuals with loss of both cyan 197 
and red fluorescence, indicating that a modification occurred that not only interrupted ECFP 198 
expression, but also interrupted expression of the DsRed marker that was over 7 kilobases away 199 
(Figure 1B). Such large deletions are not unprecedented, but are likely under-reported in 200 
studies where PCR amplicons of limited size are used to detect deletions (Kosicki et al. 2018). 201 
Injection of embryos with a reduced concentration of total gRNA (75ng/µL) produced fewer 202 
visually detectible mutations; G1 individuals with ECFP disruption were only identified from one 203 
pool of females out of 11 total female pools and single male families and constituted 0.13% of 204 
G1 individuals screened (Tables S1 and S2). No knock-outs were detectable in G1 larvae when G0 205 
embryos were injected with 500 ng/µL of Cas9 transcript or 500 ng/µL of plasmid with Cas9 206 
expressed from the Hsp70 promoter (pDCC6, Gokcezade et al. 2014) (Table S3). 207 
Optimization of injection components for adult injection: 208 
In order to accomplish heritable mutagenesis in An. stephensi by ReMOT Control, we utilized 209 
the ovary targeting P2C peptide derived from Drosophila melanogaster yolk protein 1 (DmYP1), 210 
which we recently reported in Ae. aegypti to mediate delivery of Cas9 RNP into vitellogenic 211 
oocytes (Chaverra-Rodriguez et al. 2018). However, we found that the Aedes injection 212 
parameters were not directly translatable to An. stephensi. Timing of injection of the P2C-Cas9 213 
RNP relative to a blood-meal was reported to impact the developmental stage at which genome 214 
modifications are made in Ae. aegypti. Additionally, An. stephensi have lower tolerance in 215 
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general to injected components.  We identified the injection conditions and timing that would 216 
maximize RNP uptake into the ovaries in a way that balanced survival and egg laying with 217 
concentrations of RNP effective for editing. We first injected females with P2C-EGFP fusion 218 
protein and visualized uptake into the ovary by fluorescence microscopy (Figure 2A). Green 219 
fluorescence was more intense and present in all oocytes dissected from injected females when 220 
P2C-EGFP was injected within two days of blood feeding compared to decreased fluorescence 221 
when the protein was injected prior to a blood meal. Only 50% of ovary pairs had visible 222 
fluorescence in females injected 48 hours after a blood meal, perhaps because injected females 223 
were past the peak of vitellogenesis (Nirmala et al. 2006; Isaacs et al. 2011) but those with 224 
visible fluorescence were comparable in intensity to earlier injections. Thus, experimental 225 
injections were performed within the first two days of a blood meal.  226 
In previous work, we used chloroquine to facilitate exit of the Cas9 RNP from the endosome 227 
after uptake, but previous work in the field of drug delivery has demonstrated that saponins 228 
(Quallaja bark extract) act as potent endosomal escape reagents and ongoing work in our lab 229 
optimizing ReMOT Control for Aedes suggested that it might be as or more effective (Fuchs et 230 
al. 2009; Gilabert-Oriol 2014).  For Anopheles ReMOT editing, we therefore investigated the use 231 
of saponin for endosome escape. In order to identify the highest concentration of saponin that 232 
would result in survival and viable offspring of injected adults, we performed a set of 233 
preliminary injections using different concentrations of the extract in 1X phosphate-buffered 234 
saline (PBS, Figure 2B and C). Injection itself caused substantial decrease in survival and egg 235 
laying, but a concentration of 50 mg/L saponin could be injected and still have a high enough 236 
oviposition and hatch rate to have enough G0 progeny to screen. Importantly, we also 237 
determined that An. stephensi adults could not tolerate the dialysis buffer, which is used in the 238 
last step of purification of P2C-Cas9 from E. coli (and which was the buffer used for injections in 239 
Ae. aegypti). P2C-Cas9 precipitated out of solution when diluted in water or 1X PBS. We found 240 
that the buffer of P2C-Cas9 in complex with sgRNA did not precipitate and so could be column 241 
exchanged with water resulting in a final neutral injection solution with less than 5uM KCl 242 
remaining from the dialysis buffer, and that was tolerated by injected adults.  243 
ECFP marker knockout by ReMOT Control: 244 
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P2C-Cas9 RNP with EGFP guide RNAs sgEGFP1, 2 and 3 were injected along with saponin (50 245 
mg/L) into VgCp26.10 adult females (G-1) crossed to wild-type males, such that G0 and G1 246 
progeny with parental phenotypes are either positive for both ECFP and DsRed, or wild-type. 247 
Expected mutant phenotypes from successful editing would be ECFP-, DsRed+. We recovered 248 
ECFP-, DsRed+ G0 individuals from three out of the four injection groups in which saponin was 249 
included, with a total of twelve ECFP-, DsRed + individuals out of 851 total G0 screened (1.4%). 250 
No mutant individuals were recovered from the G0 progeny in injections without saponin. The 251 
VgCp26.10 colony was not completely homozygous at the generation of adult injection, 252 
resulting in wild wild-type G0, so the efficiency of editing is more accurately understood in 253 
terms of number of alleles edited rather than the number of individuals. In this case a total of 254 
377 transgenic alleles were available for editing in the G0 progeny of saponin/P2C-Cas9 RNP 255 
injected G-1 females as visually detected by DsRed fluorescence in heterozygous G1 individuals 256 
and 14 (3.7%) were edited, whereas 0% of the 534 alleles were edited in the G0 progeny of G-1 257 
females injected without saponin. This adjustment is relevant to the extension of this technique 258 
to the mutation of endogenous mosquito genes that will be present in two copies. In these 259 
applications, especially for genes that lack a visible phenotype, editing is sufficiently efficient to 260 
be able to screen for these mutants by PCR-based methods.  261 
ECFP-, DsRed+ individuals that survived to adulthood were individually outcrossed to wild-type 262 
mosquitoes resulting in G1 progeny, of which approximately half were ECFP-,DsRed+ and half 263 
were wild-type, consistent with Mendelian segregation of two alleles (Χ2=0.0397, P=0.84) along 264 
with one transgenic mutant and one wild-type. We conclude from this that ECFP knockouts 265 
detected at G0 are complete knockouts and likely occurred as Cas9 cleavage of the DNA in the 266 
oocyte prior to embryogenesis (Table 2). Four G0 progeny were designated mosaics. One of 267 
these was ECFP positive in only one eye and the three others had markedly decreased ECFP 268 
fluorescence, which is unexpected in individuals with a transgene at a fixed location (Table 1). 269 
Individuals mosaic for mutation in a targeted gene is expected in G0, as the P2C-Cas9 editing 270 
complex can be active at different stages of development. In studies targeting the KMO gene 271 
for mutation, this manifests in patchy or pink color in the eyes instead of black eyes (Gantz et 272 
al. 2015). In our case, from the presence of fluorescence in only one eye, we infer that editing 273 
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at an early enough stage of development that a distinct pattern of fluorescence loss is seen. 274 
Conversely, in individuals with markedly decreased fluorescence, we speculate that ECFP was 275 
knocked out in some cells of the eye and not in others. We were not initially screening for 276 
mosaicism in ECFP expression, so it is likely that mosaic presence of ECFP mutations in G0 is 277 
more prevalent.  The presence of mosaicism in G0 progeny from adults injected with RNP 278 
demonstrates that, as in analogous experiments in Ae. aegypti, the complex is delivered to the 279 
G-1 ovaries, but in some cases is not immediately active, but becomes active following initiation 280 
of embryo development. G0 Individuals identified as mosaics were outcrossed but produced no 281 
progeny.  282 
ECFP+, DsRed+ individuals, which are parental in phenotype, were retained from each injection 283 
group, separated by sex and then out-crossed en masse to wild-type mosquitoes to test for the 284 
presence of germline mutations in the germline ECFP coding sequence. Wild-type G0 were 285 
excluded from further crosses. ECFP-, DsRed+ G1 offspring were recovered from one male 286 
outcross from a saponin injection group and one female outcross from a saponin negative 287 
injection group, 0.82% and 0.53% of total G1 from each group respectively. The presence of 288 
ECFP-, DsRed+ progeny from ECFP+, DsRed+ G0 mosquitoes likely represent editing of the G0 289 
germline without visible editing of the somatic tissues. 290 
A panel of four primer pairs was used to characterize ECFP-, DsRed+ modifications (Figure 3A). 291 
Two primer sets amplify across the genomic DNA and the left and right piggyBac arms of the 292 
transgene and so validate the presence of the transgene at the 26.10 locus. Similarly, a PCR 293 
amplicon using a primer set across the transgene insertion site indicates the presence of a wild-294 
type chromosome at that locus. A primer set designed to amplify 984 bp across the ECFP open 295 
reading frame and all three sgRNA target sites diagnosed the mutation character at this site: 296 
out of the 19 ECFP- knockout individuals that were molecularly characterized, only two 297 
produced diagnostic bands with ECFP primers and sequencing of the amplicons revealed small 298 
indels (Figure 3B second panel, Figure 3C and Figure S1). In 17 cases, PCR and sequencing 299 
further confirmed the presence of the transgene at the original locus, but no diagnostic band 300 
was seen from the ECFP open reading frame (Figure 3B third panel, Figure S1). In one of these, 301 
no diagnostic band was seen for amplification of either the ECFP open reading frame or the left 302 
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arm, but the right arm was validated as intact, indicating a disruption of at least 1600 303 
nucleotides of sequence (Figure 3B fourth panel). These results suggest that large deletions 304 
commonly occurred using ReMOT Control, similar to results observed from embryo injection of 305 
the same components. 306 
Altogether, we demonstrate with these experiments that heritable targeted knockouts can be 307 
achieved by ReMOT Control in An. stephensi, and that targeted editing occurs both before and 308 
after embryogenesis as evidenced both by the presence of mosaics in the G0 progeny and the 309 
recovery of ECFP-,DsRed+ G1 individuals from ECFP+,DsRed+ G0 outcrosses. Compared to 310 
embryo injection, ReMOT Control will allow non-specialist laboratories to conduct gene editing 311 
experiments in Anopheles mosquitoes and increase the number of reverse genetic studies in 312 
this malaria vector. The translation of ReMOT Control from Ae. aegypti to An. stephensi 313 
mosquitoes required modifications of the injection parameters, including timing, 314 
concentrations, and endosome escape strategies. The use of saponin dramatically increased the 315 
efficiency of knockout, consistent with results of analogous injections of the endosomal escape 316 
reagent chloroquine in the application of ReMOT Control to Ae. aegypti.  It is possible that 317 
many reagents that mediate endosomal escape are usable for ReMOT control, which will 318 
further the adaptability of this technique. The ligand P2C is broadly effective in mosquitoes 319 
(Chaverra-Rodriguez et al. 2018), and may be useful in other insect species as well. In organisms 320 
where P2C is not effective in delivery, other ligands may be identified from proteins intrinsic to 321 
that species that are specifically targeted to the germline. We anticipate that such 322 
developments along with the straight-forward set of modifications for the adaptation to An. 323 
stephensi demonstrated here, will lead to the application of P2C-Cas9 to genetic studies not 324 
only to other important malaria vectors, but also to other species currently recalcitrant to gene 325 
editing techniques.  326 
 327 
  328 
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Figure Legends: 394 
Figure 1: Schematic of knock-down approach. A) Schematic representation of transgene 395 
present in transgenic line VgCp26.10. The transgene has an ECFP and DsRed marker genes. 396 
Three guide RNAs (sgECFP) target Cas9 to the ECFP gene. B) Representative fluorescence image 397 
of larvae showing parental wild-type, parental transgenic and exceptional Cyan-, DsRed+ 398 
phenotypes. C) Schematic comparison of embryo and adult injection approaches for ECFP 399 
knock-out and detection of mutants. The shaded box represents not done. Abbreviations are 400 
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bp: base pair(s), pBac L/R: piggyBac left/right arm, SV40: simian virus 40 3’ untranslated region, 401 
DsRed: Discosoma species Red, ECFP: enhanced cyan fluorescent protein, sgECFP: single guide 402 
RNAs against ECFP, KO: knock-out, Gx: generation X. 403 
 404 
Figure 2: Optimization of injection components. A) Fluorescent and bright-field imaging of 72 405 
hours (h) post-blood meal (PBM) ovaries following injection of P2C-EGFP at 1 day (d) before and 406 
4 hours, 1 day and 2 days post-blood meal. Scale Bar represents 1mm in 40X images and 100uM 407 
in 200X images. B) Survival measurement following adult injections with different 408 
concentrations of Quillaja bark extract. C) Eggs and hatching counts from eggs laid by females 409 
injected with different concentrations of Saponin from Quillaja bark for endosome disruption. 410 
Percentages above bars represent the percentage hatching from eggs laid. Abbreviations are 411 
the same as Figure 1 and h: hour, N: number ovary pairs, pre-BM: before blood meal, PBS: 412 
phosphate buffered saline  413 
 414 
Figure 3: Molecular characterization of ECFP negative G0 and G1 reveals both small and large 415 
deletions. A) Schematic of PCR strategy for mutant genotype characterization. Left and Right 416 
Primer sets produce amplicons of 422 and 299 base pairs, respectively, that confirm the 417 
presence of the transgene at the 26.10 genomic location. ECFP amplicon, 984 bp, spans all 418 
three target sites. Primers against genomic DNA (orange and green arrows) produce a 471bp 419 
diagnostic band from a non-transgenic chromosome. B) Representative gel images from 420 
individuals with intact transgene on both chromosomes (first panel), diagnostic amplicons for 421 
both transgenic and wild-type chromosome (second panel), amplicons diagnostic for a deletion 422 
that interrupts the primer binding site for ECFP amplification (third panel) and amplicons 423 
diagnostic for a deletion that interrupts primer sites for the ECFP amplicon and the Left 424 
amplicon (fourth panel). C) Alignments of small deletion mutants from both embryo and adult 425 
injections to ECFP. Abbreviations are the same as Figure 1 and WT: wild-type, C: cyan, R: Red, 426 
PAM: protospacer motif. 427 
 428 
 429 
 430 
 431 
 432 
 433 
 434 
 435 
 436 
 437 
Table 1: Injection data and comparison of ECFP mutation by adult and embryo injections 
Injection Mix G-1 G0 Fluorescence Phenotype G1 Fluorescence Phenotype 
Protein sgCFP Saponin G-1 Cross 
No. 
Injected 
Injection 
time 
PBM 
(hours) 
No. 
on   
EC 
day 
No.  
Cyan+ Cyan- Cyan- 
Cyan 
Mosaic 
G0  
C+R+ 
Outcross 
No. 
Cyan+ Cyan- Cyan- 
DsRed+ DsRed- DsRed+ DsRed+ DsRed+ DsRed- DsRed+ 
Adult injections: P2C-Cas9/gRNA mix injections into VgCp26.10 colony females (G-1) crossed with wild type males 
0.5 
µg/µL 
0.75 
µg/µL 
+ 
VgCp26.10 
Females X WT 
Males 
300 24 212 425 106 317 
2 
(0.47%) 
0 
Female  295 103 192 0 
Male 622 324 298 0 
0.75 
µg/µL 
1.2 
µg/µL 
+ 
VgCp26.10 
Females X WT 
Males 
83 48 60 194 160 24 
10   
(5.2%) 
1*              
(1.2%) 
Female  52 26 26 0 
Male 102 38 53 
11 
(10.8%) 
0.75 
µg/µL 
1.2 
µg/µL 
+ 
VgCp26.10 
Females X WT 
Males 
63 47 33 161 52 107 
2     
(1.2%) 
1**           
(0.62%) 
Female  61 29 32 0 
Male 84 35 49 0 
0.75 
µg/µL 
1.2 
µg/µL 
+ 
VgCp26.10 
Females X WT 
Males 
78 46 46 71 41 30 0 
2**             
(2.8%) 
Female  113 30 83 0 
Male ND 
  Sap+ Totals: 524   351 851 359 478 
14 
(1.7%) 
4 (0.47%)   1329 585 733 
11 
(0.82%) 
0.75 
µg/µL 
1.1 
µg/µL 
- 
VgCp26.10 
Females X WT 
Males 
97 28 78 184 114 70 0 0 
Female  217 96 118 
3 
(1.4%) 
Male 97 49 48 0 
0.75 
µg/µL 
1.1 
µg/µL 
- 
VgCp26.10 
Females X WT 
Males 
71 25 43 173 61 112 0 0 
Female  41 15 26 0 
Male 207 109 98 0 
  Sap - Totals: 168   121 357 175 182 0 0   562 269 290 
3 
(0.53%) 
      Totals: 692   472 1208 534 660 0 0   1891 854 1023 
14 
(0.74%) 
Embryo injections: Cas9/gRNA mix injections into homozygous VgCp26.10 transgenic embryos (G0)  
0.2 
µg/µL 
0.075 
µg/µL 
- 
VgCp26.10 
Intercross 
      309 Not Screened   2320 2317 
3 
(0.13%) 
0 
0.2 
µg/µL 
0.3 
µg/µL 
- 
VgCp26.10 
Intercross 
      382 Not Screened   5646 5506 52 
(0.92%) 
88 
(1.5%) 
      
Totals: 
      691           
7966 7823 
55 
(0.69%) 
88 
(1.1%) 
*individual had one cyan+ eye and one cyan- eye 
**these individuals had markedly reduced cyan fluorescence 
Table 2: G1 progeny from Cyan negative G0 demonstrate knockouts are heritable 
G0 Cross G1 Fluorescence Phenotype 
  
No.  
Cyan+ Cyan- Cyan- 
DsRed+ DsRed- DsRed+ 
C-R+ G0 Male #1 X WT Females 246 0 123 123 
C-R+ G0 Male #2 X WT Females 163 0 86 77 
C-R+ G0 Male #3 X WT Females 275 0 141 134 
C-R+ G0 Male #5 X WT Females 119 0 58 61 
C-R+ G0 Male #6 X WT Females 339 0 170 169 
C-R+ G0 Male #9 X WT Females 116 0 56 60 
 
pBac R ECFP 3XP3 DsRed 3XP3 pBac L SV40 SV40 
7649 bp 
ECFP 3XP3 SV40 
sgECFP1 sgECFP2 sgECFP3 
26.10 genomic 
insertion site 
Cas9-mediated editing Embryo vs Adult Injection 
Embryo Adult 
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freshly laid Embryo, 
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somatic editing, visualized 
by variations in ECFP 
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Figure 1: Schematic of knock-down approach. A) Schematic representation of transgene present in transgenic line 
VgCp26.10. The transgene has an ECFP and DsRed marker genes. Three guide RNAs (sgECFP) target Cas9 to the ECFP 
gene. B) Representative fluorescence image of larvae showing parental wild-type, parental transgenic and 
exceptional Cyan-, DsRed+ phenotypes. C) Schematic comparison of embryo and adult injection approaches for 
ECFP knock-out and detection of mutants. The shaded box represents not done. Abbreviations are bp: base pair(s), 
pBac L/R: piggyBac left/right arm, SV40: simian virus 40 3’ untranslated region, DsRed: Discosoma species Red, 
ECFP: enhanced cyan fluorescent protein, sgECFP: single guide RNAs against ECFP, KO: knock-out, Gx: generation X. 
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Figure 2: Optimization of injection components. A) Fluorescent and bright-field imaging of 72 hours 
(h) post-blood meal (PBM) ovaries following injection of P2C-EGFP at 1 day (d) before and 4 hours, 1 
day and 2 days post-blood meal. Scale Bar represents 1mm in 40X images and 100uM in 200X 
images. B) Survival measurement following adult injections with different concentrations of Quillaja 
bark extract. C) Eggs and hatching counts from eggs laid by females injected with different 
concentrations of Saponin from Quillaja bark for endosome disruption. Percentages above bars 
represent the percentage hatching from eggs laid. Abbreviations are the same as Figure 1 and h: 
hour, N: number ovary pairs, pre-BM: before blood meal, PBS: phosphate buffered saline  
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Figure 3: Molecular characterization of ECFP negative G0 and G1 reveals both small and large deletions. A) 
Schematic of PCR strategy for mutant genotype characterization. Left and Right Primer sets produce amplicons 
of 422 and 299 base pairs, respectively, that confirm the presence of the transgene at the 26.10 genomic 
location. ECFP amplicon, 984 bp, spans all three target sites. Primers against genomic DNA (orange and green 
arrows) produce a 471bp diagnostic band from a non-transgenic chromosome. B) Representative gel images 
from individuals with intact transgene on both chromosomes (first panel), diagnostic amplicons for both 
transgenic and wild-type chromosome (second panel), amplicons diagnostic for a deletion that interrupts the 
primer binding site for ECFP amplification (third panel) and amplicons diagnostic for a deletion that interrupts 
primer sites for the ECFP amplicon and the Left amplicon (fourth panel). C) Alignments of small deletion 
mutants from both embryo and adult injections to ECFP. Abbreviations are the same as Figure 1 and WT: wild-
type, C: cyan, R: Red, PAM: protospacer motif. 
